Schedule 13G ownership disclosure

Corbus Pharmaceuticals Holdings Inc

Common Stock, par value $0.0001 per share · CUSIP: 21833P301

Event date: 2026-09-30

Filing-level shares
1,667,272.00
Percent of class
8.6%
  • MPM BioImpact LLC

    Shares: 1,667,272.00 · Class: 8.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001687078-26-000022
Form type
SCHEDULE 13G
Filer
MPM BioImpact LLC
CIK
CIK 1687078
Filed
Nov 13, 2026
Reporting period
Sep 30, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub